ALEMBIC PHARMACEUTICALS
Sector : Pharmaceuticals and health care | Smallcap | BSE
Here's the live share price of Alembic Pharmaceuticals along with daily highs, lows, percentage changes and volume trends, and, all financial information.
0.47₹ 4.55
As on Sep 19, 2025, 4:01 PM IST
Alembic Pharmaceuticals Price Performance
Today's LowToday's High
₹944.05₹965.55
₹963.00
52 Weeks' Low52 Weeks' High
₹725.60₹1,296.15
₹963.00
Open Price
₹961.60
Prev. Close
₹958.45
Volume
5,671
Over the last 5 years, the share price of Alembic Pharmaceuticals has gained 0.95% CAGR. Over the past year, the corresponding return has been -16.01%.
Alembic Pharmaceuticals’s current P/E of 31.39x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Best Pharmaceuticals and Healthcare Stocks Screener.
Alembic Pharmaceuticals Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Alembic Pharmaceuticals | 1.82 | -2.87 | 3.35 | 14.41 | -16.01 | 16.76 | 0.95 |
| Sun Pharmaceutical Industries | 2.46 | 1.83 | 0.53 | -4.47 | -10.31 | 23.72 | 26.88 |
| Divi's Laboratories | 2.72 | 1.77 | -4.66 | 6.42 | 13.89 | 19.59 | 14.40 |
| Cipla | 0.10 | 1.71 | 6.22 | 5.14 | -3.85 | 15.04 | 15.46 |
| Torrent Pharmaceuticals | 2.14 | -0.21 | 14.98 | 14.09 | 8.71 | 35.04 | 21.92 |
| Dr. Reddy's Laboratories | 0.55 | 6.29 | -0.21 | 12.94 | 1.71 | 17.31 | 5.19 |
| Mankind Pharma | 3.11 | 6.77 | 14.52 | 23.06 | 9.42 | 23.16 | 13.31 |
| Zydus Lifesciences | -0.75 | 4.85 | 9.18 | 14.01 | -1.65 | 42.32 | 21.23 |
| Lupin | 0.75 | 4.56 | 6.49 | -0.13 | -5.17 | 47.48 | 14.61 |
| Alkem Laboratories | 2.04 | 3.13 | 16.34 | 14.54 | -9.45 | 19.64 | 14.17 |
| Aurobindo Pharma | 2.17 | 2.57 | 3.24 | -3.89 | -26.78 | 29.10 | 7.17 |
| Abbott India | -1.82 | -8.05 | -1.97 | 0.22 | 8.72 | 20.47 | 13.85 |
| Glenmark Pharmaceuticals | -2.16 | 7.13 | 27.12 | 40.23 | 26.25 | 77.84 | 34.53 |
| Laurus Labs | 4.19 | 5.51 | 44.52 | 54.04 | 98.51 | 22.52 | 26.75 |
| Biocon | 1.26 | 1.57 | 6.05 | 8.19 | 2.48 | 8.42 | -2.92 |
| Anthem Biosciences | 1.98 | 3.87 | 16.36 | 16.36 | 16.36 | 5.18 | 3.08 |
| GlaxoSmithKline Pharmaceuticals | -1.38 | -2.86 | -14.32 | -3.47 | 1.40 | 24.71 | 10.06 |
| Ipca Laboratories | 6.86 | 1.39 | 3.24 | 3.63 | -3.35 | 17.89 | 6.17 |
| Cohance Lifesciences | -7.40 | -1.19 | -8.09 | -21.72 | -22.85 | 25.51 | 19.13 |
| Gland Pharma | 0.04 | 3.93 | 18.34 | 27.73 | 11.67 | -3.43 | 2.12 |
Over the last one year, Alembic Pharmaceuticals has declined 16.01% compared to peers like Sun Pharmaceutical Industries (-10.31%), Divi's Laboratories (13.89%), Cipla (-3.85%). From a 5 year perspective, Alembic Pharmaceuticals has underperformed peers relative to Sun Pharmaceutical Industries (26.88%) and Divi's Laboratories (14.40%).
Alembic Pharmaceuticals Financials
Alembic Pharmaceuticals Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 962.25 | 963.33 |
| 10 | 955.49 | 959.41 |
| 20 | 955.3 | 958.53 |
| 50 | 974.95 | 963.76 |
| 100 | 966.39 | 961.81 |
| 200 | 950.4 | 963.5 |
Alembic Pharmaceuticals Share Holding Pattern
In the latest quarter, Alembic Pharmaceuticals remained same as its previous close in promoter holding, while DII stake increased to 16.46%, FII holding rose to 3.96%, and public shareholding moved down to 9.91% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Alembic Pharmaceuticals Stock Mutual Fund Holdings
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| Kotak Small Cap Fund - Regular Plan | 34,27,766 | 1.83 | 321.16 |
| DSP Mid Cap Fund | 29,61,070 | 1.46 | 277.44 |
| DSP Small Cap Fund | 15,00,000 | 0.85 | 140.54 |
| Axis Small Cap Fund | 14,55,416 | 0.53 | 136.37 |
| DSP ELSS Tax Saver Fund | 14,34,898 | 0.82 | 134.44 |
| DSP Healthcare Fund | 14,28,180 | 4.31 | 133.81 |
| ICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund | 10,74,403 | 1.63 | 100.67 |
| DSP Equity & Bond Fund | 8,10,789 | 0.67 | 75.97 |
| DSP Top 100 Equity Fund | 6,08,603 | 0.89 | 57.02 |
| ICICI Prudential Smallcap Fund | 4,09,890 | 0.45 | 38.4 |
Alembic Pharmaceuticals Futures
| Price | (%) As on Invalid Date IST |
| Open Interest | (%) |
| High | |
| Low | |
| Open | |
| Close | |
| Contract Traded | |
| Turnover (in lakhs) |
Alembic Pharmaceuticals Options
Alembic Pharmaceuticals Corporate Actions
Date Time | Announcement |
|---|---|
| Sep 13, 2025, 9:22 PM IST | Alembic Pharmaceutic - Alembic Pharmaceuticals Limited Receives Establishment Inspection Report (EIR) For Its API - I & API - |
| Sep 09, 2025, 4:20 PM IST | Alembic Pharmaceutic - Announcement under Regulation 30 (LODR)-Press Release / Media Release |
| Aug 29, 2025, 4:19 PM IST | Alembic Pharmaceutic - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
| Aug 19, 2025, 4:44 PM IST | Alembic Pharmaceutic - Announcement under Regulation 30 (LODR)-Press Release / Media Release |
| Aug 19, 2025, 1:27 AM IST | Alembic Pharmaceutic - Intimation Of One On One Investor Meet |
About Alembic Pharmaceuticals
Alembic Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 16/06/2010 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is L24230GJ2010PLC061123 and registration number is 061123. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 6032.63 Cr. and Equity Capital is Rs. 39.31 Cr. for the Year ended 31/03/2025.
- IndustryPharmaceuticals
- AddressAlembic Road, Vadodra Gujarat 390003
- Contact
Management
- Mr. Chirayu AminChairman & CEO
- Mr. Pranav AminManaging Director
- Mr. Shaunak AminManaging Director
- Mr. R K BahetiDirector - Finance & CFO
- Mr. Jai DiwanjiIndependent Director
- Mr. Ashok BaratIndependent Director
- Ms. Geeta GoradiaIndependent Director
- Mr. Manish KejriwalIndependent Director
FAQs on Alembic Pharmaceuticals Share Price
What is the share price of Alembic Pharmaceuticals?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Alembic Pharmaceuticals is ₹963.00 as on Sep 19, 2025.
What kind of stock is Alembic Pharmaceuticals?
The Alembic Pharmaceuticals is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
What is the Market Cap of Alembic Pharmaceuticals?
The market cap of Alembic Pharmaceuticals is ₹18,929.03 Cr as on Sep 19, 2025.
What are today's High and Low prices of Alembic Pharmaceuticals?
Today’s highest and lowest price of Alembic Pharmaceuticals are ₹965.55 and ₹944.05.
What are the 52 Week High and 52 Week Low of Alembic Pharmaceuticals?
The 52-week high/low is the highest and lowest price at which Alembic Pharmaceuticals stock has traded in the past 52-week or nearly a year. The 52-week high of Alembic Pharmaceuticals is ₹1,296.15 and 52-week low of Alembic Pharmaceuticals is ₹725.60 as on Sep 19, 2025.
How has the Alembic Pharmaceuticals performed historically in terms of returns?
The Alembic Pharmaceuticals has shown returns of 0.47% over the past day, -2.87% for the past month, 3.35% over 3 months, -16.01% over 1 year, 16.76% across 3 years, and 0.95% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Alembic Pharmaceuticals?
P/E ratio of and PB ratio of Alembic Pharmaceuticals are 31.39 and 3.87 on Sep 19, 2025. While the company gives a dividend yield of 1.14 per annum.
Trending In Market
Stock Screener
Mutual Funds
IPO’s Open and Upcoming
Top Indices Performance
Stock Market Stats
Gold Rate Today
NSE Top Gainers
NSE Top Losers
BSE Top Gainers
BSE Top Losers
NSE 52-Week High
NSE 52-Week Low
BSE 52-Week High
BSE 52-Week Low
NSE Price Shocker
NSE Volume Shocker
BSE Price Shocker
BSE Volume Shocker
NSE Buyers
NSE Sellers
BSE Buyers
BSE Sellers
Silver Rate Today
Petrol Rate Today
Diesel Rate Today
✕
Market Data